Back to search

Article

Exploring Glypican-3 Targeted CAR-NK Treatment and Potential Therapy Resistance in Hepatocellular Carcinoma

2024-01-30

Abstract excerpt

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer and ranks as the second leading cause of cancer-related mortality globally. Despite advances in current HCC treatment, it remains a malignancy with poor prognosis. Therefore, developing novel treatment options for patients with HCC is urgently needed. Chimeric antigen receptor (CAR)-modified natural killer (NK) cells have shown poten...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
698b6f67-dea1-564d-9706-361ce9a1ddd9
DOI
10.22541/au.170664301.11370201/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring Glypican-3 Targeted CAR-NK Treatment and Potential Therapy Resistance in Hepatocellular CarcinomaDOI 10.22541/au.170664301.11370201/v1
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.Semantic proximity
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaSemantic proximity
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathwaySemantic proximity
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsideSemantic proximity
Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.Semantic proximity
Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cellsSemantic proximity
New tumor suppressor microRNAs target glypican-3 in human liver cancerSemantic proximity
B7-H3 Modulates Cell Adhesion and Immune Evasion to Promote Tumor Progression and Natural Killer Cell Resistance in Hepatocellular CarcinomaSemantic proximity
XCL1 / Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti–PD-1 EfficacySemantic proximity
Recent Progress in NKG2D CAR-NK Cells for Cancer ImmunotherapySemantic proximity
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck CancerSemantic proximity
Novel NK cell-like phenotype expressing CCR5 and its ligands elicits tumor-specific acquired immunity to carcinomatous peritonitis via host NK-derived IFN-γ.Semantic proximity
Select a neighboring publication to make it the new centre.